Clinical Trials
32 trialsELSA-FN
Murdoch Childrens Research Institute
ROSIE
Radboud University Medical Center
A Rollover Study to Provide Continued Treatment With Eltrombopag
Novartis
Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy
Duke University
Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery
McMaster University
A Web-based Study of Quality of Life Benefits Associated Aranesp in Anemic Patients With Cancer
Dartmouth-Hitchcock Medical Center
Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.
Sunnybrook Health Sciences Centre
A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT
Phoenix Children's Hospital
King's Invasive Aspergillosis Study II
King's College Hospital NHS Trust
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma
Dana-Farber Cancer Institute
Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever
Indonesia University
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
University of Maryland, Baltimore
SHORT
Amsterdam UMC, location VUmc
A Study of the Quality of Life and Treatment Response to Once Weekly Epoetin Beta (Recormon) Treatment in Anemic Participants With Solid and Lymphoid Malignancies
Hoffmann-La Roche
Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients
M.D. Anderson Cancer Center
A Study of Epoetin Beta (NeoRecormon) in Participants With Solid Tumors
Hoffmann-La Roche
A Study of Epoetin Beta (NeoRecormon) in Participants With Solid Tumors or Hematologic Malignancies
Hoffmann-La Roche
IVICA
Nottingham University Hospitals NHS Trust
Epoetin Alfa (Hemax®) Phase IV Study in Chemotherapy Induced Anemia
Bio Sidus SA
Intravenous Iron: Measuring Response in Anemic Surgical Patients
Nottingham University Hospitals NHS Trust
Epoetin Alfa in Treating Chemotherapy-Related Anemia in Women With Stage I, Stage II, or Stage III Breast Cancer
National Cancer Institute (NCI)
Epoetin Beta in Treating Anemia in Patients With Cervical Cancer
National Cancer Institute (NCI)
A Safety Study of Epoetin Alfa in Patients With Cancer Who Have Chemotherapy-Related Anemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy
Watson Pharmaceuticals
A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving Chemotherapy
Janssen-Cilag B.V.
Hematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced Anemia
Ortho Biotech Products, L.P.
A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing Chemotherapy
Janssen-Cilag B.V.
Effect of Epoetin Alfa on Hemoglobin, Symptom Distress, and Quality of Life in Patients Receiving Chemotherapy
Ortho Biotech Clinical Affairs, L.L.C.
A Study to Assess Symptom Burden in Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp®
Amgen
Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients
Sanofi
A Study to Evaluate the Effectiveness of Aranesp® for Cancer Patients With Anemia
Amgen